JRF109

N/A

Report date: 2025/08/27 15:18:36
NME

Base Information

Drug NameJRF109
Drug Alias NameJRF-109JRF109
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysine-specific histone demethylase 1 inhibitorsHistone deacetylase inhibitors
TargetsHistone deacetylaseLysine-specific histone demethylase 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaDiscontinued
Originator CompaniesChengdu Jinrui Foundation Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChengdu Jinrui Foundation Biotechnology Co Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A